1. Inhibition of pacemaker activity in interstitial cells of Cajal by LPSviaNF-κB and MAP kinase
- Author
-
Jun Lee, Young Dae Kim, Dong Chuan Zuo, Jae Yeoul Jun, Pawan K Shahi, Insuk So, In Yeoup Chang, Seok Choi, Man Yoo Kim, and Chan Guk Park
- Subjects
Lipopolysaccharides ,Male ,MAPK/ERK pathway ,Periodicity ,medicine.medical_specialty ,MAP Kinase Signaling System ,SB 203580 ,p38 mitogen-activated protein kinases ,Primary Cell Culture ,Nitric Oxide Synthase Type II ,Prostaglandin ,Biology ,Nitric Oxide ,digestive system ,Antioxidants ,Dinoprostone ,Membrane Potentials ,Mice ,symbols.namesake ,chemistry.chemical_compound ,Biological Clocks ,Internal medicine ,Intestine, Small ,medicine ,Animals ,Prostaglandin E2 ,Protein Kinase Inhibitors ,Cells, Cultured ,Mice, Inbred BALB C ,Cyclooxygenase 2 Inhibitors ,digestive, oral, and skin physiology ,NF-kappa B ,Gastroenterology ,General Medicine ,Interstitial Cells of Cajal ,Molecular biology ,Interstitial cell of Cajal ,Toll-Like Receptor 4 ,Endocrinology ,nervous system ,chemistry ,Cyclooxygenase 2 ,Mitogen-activated protein kinase ,symbols ,biology.protein ,Female ,Original Article ,Signal transduction ,medicine.drug - Abstract
AIM: To investigate lipopolysaccharide (LPS) related signal transduction in interstitial cells of Cajal (ICCs) from mouse small intestine. METHODS: For this study, primary culture of ICCs was prepared from the small intestine of the mouse. LPS was treated to the cells prior to measurement of the membrane currents by using whole-cell patch clamp technique. Immunocytochemistry was used to examine the expression of the proteins in ICCs. RESULTS: LPS suppressed the pacemaker currents of ICCs and this could be blocked by AH6809, a prostaglandin E2-EP2 receptor antagonist or NG-Nitro-L-arginine Methyl Ester, an inhibitor of nitric oxide (NO) synthase. Toll-like receptor 4, inducible NO synthase or cyclooxygenase-2 immunoreactivity by specific antibodies was detected on ICCs. Catalase (antioxidant agent) had no action on LPS-induced action in ICCs. LPS actions were blocked by nuclear factor κB (NF-κB) inhibitor, actinomycin D (a gene transcription inhibitor), PD 98059 (a p42/44 mitogen-activated protein kinases inhibitor) or SB 203580 [a p38 mitogen-activated protein kinases (MAPK) inhibitor]. SB 203580 also blocked the prostaglandin E2-induced action on pacemaker currents in ICCs but not NO. CONCLUSION: LPS inhibit the pacemaker currents in ICCs via prostaglandin E2- and NO-dependent mechanism through toll-like receptor 4 and suggest that MAPK and NF-κB are implicated in these actions.
- Published
- 2013